REVOLUTION Medicines
967 employees
Biotech/Pharma
Public · $326.0M
Open positions (145)
Company details
Team Size967
IndustryBiotech/Pharma
Funding
Total raised
$326.0M
Last stage
Public
Investors
The Column Group
Total raised
$326.0M
Last stage
Public
Investors
Martin D. Burke
Professor of chemistry at University of Illinois at Urbana-Champaign; co-founded Revolution Medicines in 2014 with Third Rock Ventures.
Michael Fischbach
Chemical biologist; joined as academic co-founder of Revolution Medicines; confirmed via company press release.
Mark A. Goldsmith
M.D., Ph.D.; founding CEO of Revolution Medicines; previously CEO of Nurix Therapeutics.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.